Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).

CompletedOBSERVATIONAL

Enrollment

230

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

March 21, 2024

Study Completion Date

April 25, 2024

Conditions

SARS-CoV 2 Pneumonia

Interventions

DRUG

Calcifediol

Calcifediol added as a treatment to the rest of the prescribed drugs of the protocol

Trial Locations (1)

Complejo Hospitalario Universitario de Albacete, Albacete

All Listed Sponsors

lead

Complejo Hospitalario Universitario de Albacete

OTHER

NCT06279910 - Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19). | Biotech Hunter | Biotech Hunter